UiPath, Inc. (NYSE:PATH – Get Free Report) has earned a consensus recommendation of “Hold” from the seventeen brokerages that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $13.8667.
Several research analysts recently issued reports on the stock. Morgan Stanley dropped their price target on shares of UiPath from $17.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, May 29th. TD Cowen decreased their price target on shares of UiPath from $16.00 to $13.00 and set a “hold” rating on the stock in a research note on Thursday, March 12th. Needham & Company LLC reaffirmed a “buy” rating and issued a $15.00 price objective on shares of UiPath in a research note on Friday, May 29th. DA Davidson reduced their target price on UiPath from $13.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, May 29th. Finally, Canaccord Genuity Group reduced their price target on shares of UiPath from $19.00 to $15.00 and set a “buy” rating on the stock in a research report on Thursday, March 12th.
View Our Latest Stock Report on UiPath
UiPath Stock Performance
UiPath (NYSE:PATH – Get Free Report) last issued its earnings results on Thursday, May 28th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15. UiPath had a net margin of 19.58% and a return on equity of 7.92%. The company had revenue of $418.38 million during the quarter, compared to analyst estimates of $397.54 million. During the same quarter last year, the business posted $0.11 EPS. The company’s revenue for the quarter was up 17.3% on a year-over-year basis. On average, sell-side analysts expect that UiPath will post 0.38 EPS for the current fiscal year.
Institutional Investors Weigh In On UiPath
A number of institutional investors and hedge funds have recently made changes to their positions in PATH. Noble Wealth Management PBC acquired a new stake in UiPath during the 4th quarter valued at $25,000. HighMark Wealth Management LLC acquired a new stake in UiPath during the 4th quarter valued at $25,000. Raleigh Capital Management Inc. acquired a new stake in UiPath during the 4th quarter valued at $26,000. TD Waterhouse Canada Inc. raised its holdings in UiPath by 1,270.8% in the 4th quarter. TD Waterhouse Canada Inc. now owns 1,782 shares of the company’s stock valued at $29,000 after acquiring an additional 1,652 shares during the period. Finally, Atlas Capital Advisors Inc. acquired a new stake in UiPath during the fourth quarter worth approximately $37,000. Institutional investors own 62.50% of the company’s stock.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.
Recommended Stories
- Five stocks we like better than UiPath
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.
